Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Cash from Financing Activities (2019 - 2025)

BioScience Health Innovations (BHIC) has disclosed Cash from Financing Activities for 7 consecutive years, with -$366016.0 as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 191.82% to -$366016.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$115920.0 through Dec 2025, down 117.94% year-over-year, with the annual reading at -$115920.0 for FY2025, 117.94% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$366016.0 at BioScience Health Innovations, down from $180461.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $398602.0 in Q4 2024, with the low at -$366016.0 in Q4 2025.
  • Average Cash from Financing Activities over 5 years is $62285.2, with a median of $66042.0 recorded in 2023.
  • The sharpest move saw Cash from Financing Activities skyrocketed 1383.85% in 2021, then plummeted 191.82% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $100000.0 in 2021, then crashed by 60.0% to $40000.0 in 2022, then dropped by 15.73% to $33707.0 in 2023, then skyrocketed by 1082.55% to $398602.0 in 2024, then tumbled by 191.82% to -$366016.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$366016.0, $180461.0, and $2119.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.